comparemela.com

Latest Breaking News On - Nantes university - Page 11 : comparemela.com

OSE Immunotherapeutics To Present at Immuno-Oncology Summit Europe and at Tumor Myeloid-Directed Therapies Summit In London and Boston

OSE Immunotherapeutics To Present at Immuno-Oncology Summit Europe and at Tumor Myeloid-Directed Therapies Summit In London and Boston
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

OSE Immunotherapeutics Announces New European Patent Granted Covering CLEC-1, Novel Myeloid Immune Checkpoint Target For Cancer Immunotherapy

OSE Immunotherapeutics Announces New European Patent Granted Covering CLEC-1, Novel Myeloid Immune C

A new protection covering CLEC-1 antagonists until 2037Patent also granted in Japan and notice of allowance granted in the USNANTES, France (BUSINESS WIRE) Regulatory News:OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced the grant of a new patent from the European Patent Offic.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.